NO20042181L - Antibiotiske GE 81112-faktorer A, B, B1, farmasoytisk akseptable salter og sammensetninger samt anvendelse derav - Google Patents

Antibiotiske GE 81112-faktorer A, B, B1, farmasoytisk akseptable salter og sammensetninger samt anvendelse derav

Info

Publication number
NO20042181L
NO20042181L NO20042181A NO20042181A NO20042181L NO 20042181 L NO20042181 L NO 20042181L NO 20042181 A NO20042181 A NO 20042181A NO 20042181 A NO20042181 A NO 20042181A NO 20042181 L NO20042181 L NO 20042181L
Authority
NO
Norway
Prior art keywords
antibiotic
pharmaceutically acceptable
acceptable salts
factors
compositions
Prior art date
Application number
NO20042181A
Other languages
English (en)
Norwegian (no)
Inventor
Enrico Selva
Alessandra Maria Marazzi
Flavia Marinelli
Daniele Losi
Linda Cavaletti
Ameriga Lazzarini
Original Assignee
Vicuron Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicuron Pharm Inc filed Critical Vicuron Pharm Inc
Publication of NO20042181L publication Critical patent/NO20042181L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO20042181A 2001-11-28 2004-05-26 Antibiotiske GE 81112-faktorer A, B, B1, farmasoytisk akseptable salter og sammensetninger samt anvendelse derav NO20042181L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01128204 2001-11-28
PCT/EP2002/011113 WO2003046192A1 (fr) 2001-11-28 2002-10-04 Antibiotiques facteurs a, b, b1 du ge 81112, leurs sels pharmacocompatibles, leurs compositions, et leurs utilisations

Publications (1)

Publication Number Publication Date
NO20042181L true NO20042181L (no) 2004-08-04

Family

ID=8179366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042181A NO20042181L (no) 2001-11-28 2004-05-26 Antibiotiske GE 81112-faktorer A, B, B1, farmasoytisk akseptable salter og sammensetninger samt anvendelse derav

Country Status (22)

Country Link
US (3) US7407654B2 (fr)
EP (1) EP1448784B1 (fr)
JP (1) JP4452505B2 (fr)
KR (1) KR20040099257A (fr)
CN (1) CN1596312A (fr)
AT (1) ATE390490T1 (fr)
AU (2) AU2002365433A1 (fr)
BR (1) BR0214494A (fr)
CA (1) CA2468400A1 (fr)
DE (1) DE60225834T2 (fr)
ES (1) ES2299635T3 (fr)
HR (1) HRP20040471A2 (fr)
HU (1) HUP0402383A3 (fr)
IL (1) IL161896A0 (fr)
MX (1) MXPA04005032A (fr)
NO (1) NO20042181L (fr)
NZ (1) NZ533732A (fr)
PL (1) PL370451A1 (fr)
RU (1) RU2004119432A (fr)
WO (1) WO2003046192A1 (fr)
YU (1) YU46804A (fr)
ZA (1) ZA200403675B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005032A (es) * 2001-11-28 2004-08-11 Vicuron Pharm Inc Antibioticos de factores a,b y b1 de ge 81112, sus composiciones, sales farmaceuticamente aceptables y uso de los mismos.
US11744859B2 (en) 2017-07-07 2023-09-05 Epicentrx, Inc. Compositions and methods for parenteral administration of therapeutic agents
KR102408301B1 (ko) * 2020-03-16 2022-06-10 강원대학교산학협력단 항균 활성을 갖는 신균주 스트렙토마이세스 sbc-4 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043353A (en) 1989-10-10 1991-08-27 Eli Lilly And Company A80789 polyether antibiotic
KR960703410A (ko) 1992-12-22 1996-08-17 프란세스코 마체타 항생물질 GE 37468 A, B 및 C(Antibiotics GE 37468 A, B and C)
US5432193A (en) 1993-05-14 1995-07-11 American Cyanamid Company Antibiotic LL-D37187α
US5426108A (en) * 1993-11-10 1995-06-20 American Cyanamid Company Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2
US5486630A (en) 1994-09-14 1996-01-23 Cheil Foods & Chemicals Inc. Legionella specific antibiotic
MXPA04005032A (es) * 2001-11-28 2004-08-11 Vicuron Pharm Inc Antibioticos de factores a,b y b1 de ge 81112, sus composiciones, sales farmaceuticamente aceptables y uso de los mismos.

Also Published As

Publication number Publication date
HRP20040471A2 (en) 2004-10-31
KR20040099257A (ko) 2004-11-26
EP1448784A1 (fr) 2004-08-25
BR0214494A (pt) 2004-10-19
JP4452505B2 (ja) 2010-04-21
AU2002365433A1 (en) 2003-06-10
ES2299635T3 (es) 2008-06-01
EP1448784B1 (fr) 2008-03-26
RU2004119432A (ru) 2006-01-10
US20110286996A1 (en) 2011-11-24
DE60225834T2 (de) 2009-04-09
HUP0402383A3 (en) 2008-03-28
AU2008255202A1 (en) 2009-01-08
US7407654B2 (en) 2008-08-05
US8007789B2 (en) 2011-08-30
ATE390490T1 (de) 2008-04-15
MXPA04005032A (es) 2004-08-11
JP2005510573A (ja) 2005-04-21
US20050020514A1 (en) 2005-01-27
ZA200403675B (en) 2005-05-13
US20090023665A1 (en) 2009-01-22
CN1596312A (zh) 2005-03-16
WO2003046192A1 (fr) 2003-06-05
PL370451A1 (en) 2005-05-30
NZ533732A (en) 2005-05-27
HUP0402383A2 (hu) 2005-02-28
YU46804A (sh) 2006-08-17
CA2468400A1 (fr) 2003-06-05
IL161896A0 (en) 2005-11-20
DE60225834D1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
WO2005000878A8 (fr) Compositions a base de derives antibiotiques de la classe des lipopeptides et leurs methodes d'utilisation
PL404913A1 (pl) Zwiazek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy
WO2007064954A3 (fr) Analogues d'aminoglycoside 4,5-substitués antibactériens comportant plusieurs substituants
AU3196900A (en) Preventives/remedies for interstitial pneumonia and pulmonary fibrosis
WO2008041966A3 (fr) Composés antibactériens à large spectre
WO2005014585A8 (fr) Quinazolinyl nitrofuranes halogenes utilises comme agents antibacteriens
MX2010004407A (es) Antibioticos de carbacefem beta-lactama.
BR0012253A (pt) Derivado de 1-metilcarbapenem, composição farmacêutica para a prevenção ou tratamento de infecções bacterianas, uso de uma forma cristalina de derivado de 1-metilcarbapenem, e, método para a prevenção ou tratamento de infecções bacterianas
MXPA06000691A (es) Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables y uso de las mismas.
TWI256292B (en) Reduction inhibitory agent for active oxygen eliminating activity
WO2006055070A3 (fr) Nouveaux derives de lincomycine possedant une activite anti-microbienne
NO20042181L (no) Antibiotiske GE 81112-faktorer A, B, B1, farmasoytisk akseptable salter og sammensetninger samt anvendelse derav
WO2004016632A8 (fr) Derives de lincomycine presentant une activite antibacterienne
KR102574692B9 (ko) 신규 미생물 바실러스 벨레젠시스 cmml21-47 또는 이를 함유하는 미생물 제제
CA2380455A1 (fr) 9a-azalides a activite antibacterienne
WO2010036000A3 (fr) Nouveaux dérivés d'oxazolidinone avec une amidoxime cyclique ou une amidrazone cyclique et compositions pharmaceutiques les comprenant
DE60006690D1 (de) Antibiotische caprazamycine und verfahren zu deren herstellung
WO2004098500A3 (fr) Beta-lactamine de la classe des carbacephems
MX2007009059A (es) Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables, y uso de los mismos.
WO2000010998A3 (fr) Antibiotique au pyridone a profil d'innocuite ameliore
WO2003101405A3 (fr) Antibiotiques a base d'amino-glycosides et procedes d'utilisation correspondants
WO2004004646A3 (fr) Derives de nocathiacine o-derivatises
UA70974C2 (uk) Ванкорезміцин (варіанти), штам amycolatopsis виду hil-006734, dsm 12216, що його продукує, та фармацевтична композиція, яка має антибіотичну активність
WO2004108744A3 (fr) Azalides et azaketolides possedant une activite antimicrobienne
ATE369352T1 (de) Hki10311129, neues antibiotikum, verfahren zu dessen herstellung und dessen verwendung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application